About the Congress
OCT-angiography is a new non-invasive technology for studying the blood flow of the retina and choroid,
which undoubtedly claims to become the diagnostic standard in ophthalmology in the coming years.
Already today ideas about the pathogenesis and classification of many diseases have changed due to OCTA.
The goal of the Congress is to unite like-minded people: doctors, engineers, researchers in the field of OCTA,
to create a platform in which it will be possible to discuss pressing issues and share their discoveries,
and we are sure that with each passing year there will be more and more!
which undoubtedly claims to become the diagnostic standard in ophthalmology in the coming years.
Already today ideas about the pathogenesis and classification of many diseases have changed due to OCTA.
The goal of the Congress is to unite like-minded people: doctors, engineers, researchers in the field of OCTA,
to create a platform in which it will be possible to discuss pressing issues and share their discoveries,
and we are sure that with each passing year there will be more and more!
ОСТА 2025
Location & Adress
We are waiting for you at VII annual Congress OCTA 25 which will be held on June 11, 2025 in the Northern capital. At the height of the white nights, a new design platform will open its doors for you "LOFT #7 BRYULOV HALL",
Saint Petersburg, Arsenalnaya Embankment, 1
LOFT #7 BRYULOV HALL
LOFT HALL
LOFT HALL
Saint Petersburg, Arsenalnaya Embankment, 1
6 minutes away from Ploschad Lenina metro station
6 minutes away from Ploschad Lenina metro station
Program of ОCTA 25
June 11, 2025
8:00 – 8:20
Registration of guests
8:20 – 9:55
I. Interesting Clinical Cases
Speakers: V.V. Alekseykova, D.B. Babaeva, Yu.S. Galchenkova, A.S. Derbeneva, T.A. Doktorova, Ya.A. Kalinicheva, S.Yu. Kalinnikova, I.I. Malinovskaya, I.F. Nikulich, M.A. Poroshina, S.O. Romanenko, R.M. Sutyshev, D.V. Khaleeva, A.F. Yafyasova.
10:00 – 11:00
10.00
10.00 - 10.10
10.15 - 10.35
10.40 - 11.00
II. Progress and Controversies in the Diagnosis and Treatment of Retinal Diseases
Opening of the Congress
OCTA in the assessment of foveal displacement in vitreoretinal pathology
A.N. Kulikov
A DRAMA-tic debut or sovereign progression? Controversies surrounding Type III MNV
A.Zh. Fursova
En face OCT: current progress in understanding normal anatomy and posterior segment diseases
D.S. Maltsev
10-minute break
OCTA in the assessment of foveal displacement in vitreoretinal pathology
A.N. Kulikov
A DRAMA-tic debut or sovereign progression? Controversies surrounding Type III MNV
A.Zh. Fursova
En face OCT: current progress in understanding normal anatomy and posterior segment diseases
D.S. Maltsev
10-minute break
11:15 – 12:40
11.15 - 11.30
11.35 - 11.50
11.55 - 12.10
12.15 - 12.40
11.15 - 11.30
11.35 - 11.50
11.55 - 12.10
12.15 - 12.40
III. OCTA Biomarkers
Updating OCT-Angiography Biomarkers in Clinical Practice
G.M. Arslanov
Retinal Nerve Fiber Layer in Systemic Vascular Diseases
M.A. Burnasheva
Mysterious Hyperreflective Inclusions in the Choroid
A.N. Stulova
Alice in Wonderland. Chapter I. The Eight of Hearts Testifies
A.Zh. Fursova, N.S. Semenova, E.K. Pedanova, F.E. Shadrichev
Lunch Break
G.M. Arslanov
Retinal Nerve Fiber Layer in Systemic Vascular Diseases
M.A. Burnasheva
Mysterious Hyperreflective Inclusions in the Choroid
A.N. Stulova
Alice in Wonderland. Chapter I. The Eight of Hearts Testifies
A.Zh. Fursova, N.S. Semenova, E.K. Pedanova, F.E. Shadrichev
Lunch Break
01:30 – 01:45 pm
IV. Technical Innovations in OCTA
Strategies and Paradigms 25/30
D.A. Mashkov
D.A. Mashkov
01:50 – 02:50 pm
01.50 - 02.05
02.10 - 02.30
02.35 - 02.50
01.50 - 02.05
02.10 - 02.30
02.35 - 02.50
V. Glaucoma
Diagnostic Value of OCT Biomarkers in the Progression of Primary Open-Angle Glaucoma and Myopia
Yu.A. Guseva
Differential Diagnosis of Glaucomatous and Non-Glaucomatous Optic Neuropathy
S.I. Zhukova
Changes in Optic Disc Hemodynamics Under Induced High Intraocular Pressure
L.L. Arutyunyan
10-minute break
Yu.A. Guseva
Differential Diagnosis of Glaucomatous and Non-Glaucomatous Optic Neuropathy
S.I. Zhukova
Changes in Optic Disc Hemodynamics Under Induced High Intraocular Pressure
L.L. Arutyunyan
10-minute break
03:00 – 05:10 pm
03.00 - 03.15
03.20 - 03.35
03.40 - 03.55
04.00 - 04.15
04.20 - 04.35
04.40 - 04.55
05.00 - 05.15
03.00 - 03.15
03.20 - 03.35
03.40 - 03.55
04.00 - 04.15
04.20 - 04.35
04.40 - 04.55
05.00 - 05.15
VI. Retina
Perfusion Status During Anti-VEGF Therapy – Practical Points for Interpretation
T.B. Shaimov
OCTA in the Diagnosis of Peripheral Proliferative Retinopathy. Who is to Blame? What to Do?
E.Yu. Zubkova
OCTA Phenomena in Pathological Myopia
A.N. Panfilova
Ischemic Maculopathies
A.A. Suetov
Susac Syndrome – Occlusive and Non-Occlusive Retinovasculitis
M.A. Vasileva
OCTA in Hereditary Retinal Dystrophies
O.M. Stanishevska
VKH and VKH-like Pathology
A.A. Voskresenskaya
5-minute break
T.B. Shaimov
OCTA in the Diagnosis of Peripheral Proliferative Retinopathy. Who is to Blame? What to Do?
E.Yu. Zubkova
OCTA Phenomena in Pathological Myopia
A.N. Panfilova
Ischemic Maculopathies
A.A. Suetov
Susac Syndrome – Occlusive and Non-Occlusive Retinovasculitis
M.A. Vasileva
OCTA in Hereditary Retinal Dystrophies
O.M. Stanishevska
VKH and VKH-like Pathology
A.A. Voskresenskaya
5-minute break
05:20 - 06:10 pm
VII. Lecture
Rethinking Macular Atrophy
N.S. Semenova, E.K. Pedanova
N.S. Semenova, E.K. Pedanova
06:10 - 07:40 pm
Closing of the Congress. Buffet.
Program of ОCTA 25
June 11, 2025
8:00 – 8:20 am
Registration of guests
8:20 – 9:55 am
I. Interesting Clinical Cases
Speakers: V.V. Alekseykova, D.B. Babaeva, Yu.S. Galchenkova, A.S. Derbeneva, T.A. Doktorova, Ya.A. Kalinicheva, S.Yu. Kalinnikova, I.I. Malinovskaya, I.F. Nikulich, M.A. Poroshina, S.O. Romanenko, R.M. Sutyshev, D.V. Khaleeva, A.F. Yafyasova.
10:00 – 11:00 am
II. Progress and Controversies in the Diagnosis and Treatment of Retinal Diseases
10.00 - Opening of the Congress
10.15 - 10.35
A DRAMA-tic debut or sovereign progression? Controversies surrounding Type III MNV
A.Zh. Fursova
10.40 - 11.00
En face OCT: current progress in understanding normal anatomy and posterior segment diseases
D.S. Maltsev
10-minute break
10.00 - 10.10
OCTA in the assessment of foveal displacement in vitreoretinal pathologyA.N. Kulikov
10.15 - 10.35
A DRAMA-tic debut or sovereign progression? Controversies surrounding Type III MNV
A.Zh. Fursova
10.40 - 11.00
En face OCT: current progress in understanding normal anatomy and posterior segment diseases
D.S. Maltsev
10-minute break
11:15 – 12:40
III. OCTA Biomarkers
11.15 - 11.30
Updating OCT-Angiography Biomarkers in Clinical Practice
G.M. Arslanov
11.35 - 11.50
Retinal Nerve Fiber Layer in Systemic Vascular Diseases
M.A. Burnasheva
11.55 - 12.10
Mysterious Hyperreflective Inclusions in the Choroid
A.N. Stulova
12.15 - 12.40
Alice in Wonderland. Chapter I. The Eight of Hearts Testifies
A.Zh. Fursova, N.S. Semenova, E.K. Pedanova, F.E. Shadrichev
Lunch Break
01:30 – 01:45 pm
IV. Technical Innovations in OCTA
Strategies and Paradigms 25/30
D.A. Mashkov
D.A. Mashkov
01:50 – 02:50 pm
V. Glaucoma
01.50 - 02.05
Diagnostic Value of OCT Biomarkers in the Progression of Primary Open-Angle Glaucoma and Myopia
Yu.A. Guseva
02.10 - 02.30
Differential Diagnosis of Glaucomatous and Non-Glaucomatous Optic Neuropathy
S.I. Zhukova
02.35 - 02.50
Changes in Optic Disc Hemodynamics Under Induced High Intraocular Pressure
L.L. Arutyunyan
10-minute break
Diagnostic Value of OCT Biomarkers in the Progression of Primary Open-Angle Glaucoma and Myopia
Yu.A. Guseva
02.10 - 02.30
Differential Diagnosis of Glaucomatous and Non-Glaucomatous Optic Neuropathy
S.I. Zhukova
02.35 - 02.50
Changes in Optic Disc Hemodynamics Under Induced High Intraocular Pressure
L.L. Arutyunyan
10-minute break
03:00 – 05:10 pm
VI. Retina
03.00 - 03.15
Perfusion Status During Anti-VEGF Therapy – Practical Points for Interpretation
T.B. Shaimov
03.20 - 03.35
OCTA in the Diagnosis of Peripheral Proliferative Retinopathy. Who is to Blame? What to Do?
E.Yu. Zubkova
03.40 - 03.55
OCTA Phenomena in Pathological Myopia
A.N. Panfilova
04.00 - 04.15
Ischemic Maculopathies
A.A. Suetov
04.20 - 04.35
Susac Syndrome – Occlusive and Non-Occlusive Retinovasculitis
M.A. Vasileva
04.40 - 04.55
OCTA in Hereditary Retinal Dystrophies
O.M. Stanishevska
05.00 - 05.15
VKH and VKH-like Pathology
A.A. Voskresenskaya
5-minute break
Perfusion Status During Anti-VEGF Therapy – Practical Points for Interpretation
T.B. Shaimov
03.20 - 03.35
OCTA in the Diagnosis of Peripheral Proliferative Retinopathy. Who is to Blame? What to Do?
E.Yu. Zubkova
03.40 - 03.55
OCTA Phenomena in Pathological Myopia
A.N. Panfilova
04.00 - 04.15
Ischemic Maculopathies
A.A. Suetov
04.20 - 04.35
Susac Syndrome – Occlusive and Non-Occlusive Retinovasculitis
M.A. Vasileva
04.40 - 04.55
OCTA in Hereditary Retinal Dystrophies
O.M. Stanishevska
05.00 - 05.15
VKH and VKH-like Pathology
A.A. Voskresenskaya
5-minute break
05:20 - 06:10 pm
VII. Lecture
Rethinking Macular Atrophy
N.S. Semenova, E.K. Pedanova
N.S. Semenova, E.K. Pedanova
06:10 - 07:40 pm
Closing of the Congress. Buffet.
ОCТА 2024 PHOTO REPORT
News and events
MOPTIM MOCEAN 4000
REGISTERED IN RUSSIA
We are pleased to announce that the Moptim Mocean 4000 optical coherence tomograph has been officially registered in the Russian Federation. The device has received its registration certificate and is ready for clinical use within the country.
(Registration Number: RZN 2025/25566)
The Mocean 4000 is a modern solution for diagnosing retinal and anterior segment diseases, combining high resolution, a wide field of view, and ease of use. Its introduction is expected to significantly expand the capabilities of ophthalmologists in everyday practice.
(Registration Number: RZN 2025/25566)
The Mocean 4000 is a modern solution for diagnosing retinal and anterior segment diseases, combining high resolution, a wide field of view, and ease of use. Its introduction is expected to significantly expand the capabilities of ophthalmologists in everyday practice.
Processing images using HOCT-1F
3 YEARS with Deep Machine Learning algorithm!
Recently, three years have passed since the beginning of the active application of the Deep Machine Learning algorithm to improve the accuracy of retinal layer segmentation in images obtained using the HOCT-1F optical coherence tomograph from Huvitz, South Korea.
This technology has significantly simplified the diagnosis in complex clinical cases, both in retinal diseases and in optic nerve pathology. It is important to note that the Deep Machine Learning algorithm is used in the basic configuration of the device and is available to all users by default.
This technology has significantly simplified the diagnosis in complex clinical cases, both in retinal diseases and in optic nerve pathology. It is important to note that the Deep Machine Learning algorithm is used in the basic configuration of the device and is available to all users by default.
New generation of OCT with AI
MOPTIM MOCEAN 4000
Introducing the new Mocean 4000: The OCT software has the ability to use the most modern and advanced artificial intelligence algorithms developed by Moptim, which are aimed at improving the quality of visualization of structural OCT 12x12 mm zone and OCTA. Thanks to this, high-quality analysis of retinal structures, even with initial changes, becomes easier
03.12.2023
ICOOR 2023
From November 30 to December 3, the 11th International Conference on OCT and OCT Angiography ICOOR 2023 was held in Rome.
Russia was represented at the Сongress by Dmitry Maltsev, who made two reports there.
Russia was represented at the Сongress by Dmitry Maltsev, who made two reports there.
MOPTIM
Mocean 4000
Mocean 4000 - a new product with a Great Future!
The presence of a laser scanning ophthalmoscope is a distinctive feature of Mocean 4000. This fact brings this Chinese to the level of the best European manufacturers of OСT. MOPTIM company, founded in 2003, confidently holds the first place.
The name MOPTIM stands for Medical Optical Imaging. Since 2005, MOPTIM has been cooperating with Tsinghua University and is a co-founder of a research laboratory engaged in advanced research in the field of OCT and OCTA.
Now Mocean 4000 optical coherence tomograph is being registered, but we hope that in the near future it will successfully work in diagnostic rooms.
The presence of a laser scanning ophthalmoscope is a distinctive feature of Mocean 4000. This fact brings this Chinese to the level of the best European manufacturers of OСT. MOPTIM company, founded in 2003, confidently holds the first place.
The name MOPTIM stands for Medical Optical Imaging. Since 2005, MOPTIM has been cooperating with Tsinghua University and is a co-founder of a research laboratory engaged in advanced research in the field of OCT and OCTA.
Now Mocean 4000 optical coherence tomograph is being registered, but we hope that in the near future it will successfully work in diagnostic rooms.
18.12.2021
ICOOR 2021
On December 17-18, 2021, the annual, ninth in a row, International Conference on OCT and OCT angiography ICOOR 2021 was held in Rome.
13.11.2021
"Ecology and Human Health
in the North"
in the North"
Yakutsk hosted the annual Congress "Ecology and Human Health
in the North"
in the North"
28.02.2021
Professional development cycle on OCT completed
At the end of February, the cycle of advanced training for ophthalmologists "Optical coherence tomography in ophthalmology: theory and practice" was completed.
OCTA 2023
OCTA 2022
OCTA 2021
OCTA 2020
OCTA 2019
Contact us
+7 (925) 460-62-46
info@octangio.ru
info@octangio.ru
© 2019 SP Arefieva Julia Arkadyevna. All Rights Reserved